Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents

By de Vries P.   Singer J.W.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 916-923

Elsevier

Access to resources Recommend Favorite

Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution

By  

Current Molecular Medicine, Vol. 12, Iss. 9, 2012-11 ,pp. : 1108-1124

Bentham Science Publishers

Access to resources Recommend Favorite

17 AAG for HSP90 Inhibition in Cancer - From Bench to Bedside

By  

Current Molecular Medicine, Vol. 9, Iss. 5, 2009-06 ,pp. : 654-664

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic interactions of the anticasein kinase 2 CIGB300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 935-944

Spandidos Publications

Access to resources Recommend Favorite

Elevated Levels of the 90 kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90

By Ripley B.J.M.   Isenberg D.A.   Latchman D.S.  

Journal of Autoimmunity, Vol. 17, Iss. 4, 2001-12 ,pp. : 341-346

Academic Press

Access to resources Recommend Favorite